Global life sciences BluePrint Research Group specializes in shaping go-to-market strategies for life sciences decision makers with a global footprint, presenting sales opportunities to partner for strategic market access, product launch support, and international expansion services.

Acquisition signal Recent acquisition by Trinity Partners indicates a market consolidation trend and potential cross-sell opportunities to complement their extended capabilities in commercial strategy and analytics for pharma, biopharma, and medtech clients.

Diverse client base With 55+ clients annually across pharma, biopharma, and medtech and a global reach spanning Europe, Latin America, Canada, Asia Pacific, and the Middle East, there are ripe opportunities to target large as well as mid-market life sciences companies seeking strategic guidance and actionable insights.

Innovation focus An active innovation lab and ongoing product/service expansion suggest upsell potential for clients seeking enhanced analytics, advisory deliverables, and new commercial strategy offerings that differentiate them from competitors.

Smaller firm agility With a lean team size and a global, multi-office presence, BluePrint presents a compelling partner for bespoke, high-touch engagements, enabling sales conversations around customized solutions, flexible engagement models, and rapid scoping for strategic initiatives.